| Members |
targetComponentId |
| Subakut endokardit, ikke nærmere specificeret |
Subacute endocarditis |
| Subacute leukemia |
Leukaemia |
| Subacute leukemia |
Leukaemia |
| Subacute leukemia in remission |
Leukaemia in remission |
| Subacute lymphoid leukemia in remission |
Lymphoid leukemia in remission |
| Subacute monocytic leukemia |
Subacute leukaemia |
| Subakut monocytleukæmi |
Subacute leukaemia |
| Subacute monocytic leukemia |
Myeloid neoplasm (morphologic abnormality) |
| Subacute monocytic leukemia in remission |
Myeloid leukemia in remission |
| Subacute myeloid leukemia |
Subacute leukaemia |
| subakut myeloid leukæmi |
Subacute leukaemia |
| Subacute myeloid leukemia |
Myeloid leukaemia |
| subakut myeloid leukæmi i remission |
Subacute leukemia in remission (disorder) |
| Subacute myeloid leukemia in remission |
Myeloid leukemia in remission |
| Subakut myoendokardit, ikke nærmere specificeret |
Subacute myoendocarditis |
| Subakut periendokardit, ikke nærmere specificeret |
Subacute periendocarditis |
| Subakut gul leveratrofi |
Subacute hepatic necrosis |
| subaortisk divertikel |
Diverticulum |
| Subarachnoid hemorrhage following injury with open intracranial wound and unspecified state of consciousness |
Subarachnoid hemorrhage following injury with open intracranial wound |
| subkronisk latent skizofreni |
Schizotypal personality disorder |
| Subclass Mycobacteria |
Subclass Actinobacteridae (organism) |
| Subclass: Araneae |
Order Araneae (organism) |
| Subconjunctival injection - local action |
Subconjunctival injection |
| subkonjunktival injektion mhp. lokal virkning |
Subconjunctival injection |
| Subcutaneous injection (& for local action) |
Injection into subcutaneous tissue (procedure) |
| Subcutaneous injection NOS |
Injection into subcutaneous tissue (procedure) |
| subkutan injektion mhp. lokal virkning |
Injection into subcutaneous tissue (procedure) |
| Subcutaneous injection for local action NEC |
Injection into subcutaneous tissue (procedure) |
| Subcutaneous injection of Pneumovax II |
Subcutaneous injection of pneumococcal vaccine |
| subkutan injektion af Pneumovax II |
Subcutaneous injection of pneumococcal vaccine |
| Subcutaneous tissue of ankle and foot |
Subcutaneous tissue structure of lower extremity |
| Subcutaneous tissue of anterior surface of leg |
Subcutaneous tissue structure of anterior surface of lower leg |
| Subcutaneous tissue of arm and elbow |
Subcutaneous tissue structure of upper extremity |
| Subcutaneous tissue of arm and shoulder |
Subcutaneous tissue structure of upper extremity |
| Subcutaneous tissue of arm and wrist |
Subcutaneous tissue structure of upper extremity |
| Subcutaneous tissue of forearm and wrist |
Subcutaneous tissue structure of upper extremity |
| Subcutaneous tissue of gluteal fold of lower extremity |
Subcutaneous tissue structure of lower extremity |
| Subcutaneous tissue of hand and forearm |
Subcutaneous tissue structure of upper extremity |
| Subcutaneous tissue of leg and ankle |
Subcutaneous tissue structure of lower extremity |
| Subcutaneous tissue of leg and hip |
Subcutaneous tissue structure of lower extremity |
| Subcutaneous tissue of lower extremity and hip |
Subcutaneous tissue structure of lower extremity |
| Subcutaneous tissue of perineum and lower extremities |
Subcutaneous tissue structure of lower extremity |
| Subcutaneous tissue of upper extremity and shoulder |
Subcutaneous tissue structure of upper extremity |
| Subcutaneous tissue of wrist and hand |
Subcutaneous tissue structure of upper extremity |
| Subdural hemorrhage following injury with open intracranial wound and unspecified state of consciousness |
Subdural hemorrhage following open wound of head (disorder) |
| Subdural hemorrhage following injury without open intracranial wound with unspecified state of consciousness |
Closed traumatic subdural haemorrhage |
| initial subdural udtømning gennem fontanel hos spædbarn |
Subdural tap through fontanel |
| Subfamily Acinonychinae |
Subfamily Felinae (organism) |
| Subfamily Ailurinae |
Family Ailuridae (organism) |
| Subfamily Coronavirinae |
Subfamily Orthocoronavirinae (organism) |
| Subfamily Cryptoproctinae |
Subfamily Euplerinae (organism) |
| Subfamily Ctenomyinae |
Tribe Ctenomyini (organism) |
| Subfamily Herpestinae |
Family Herpestidae (organism) |
| Subfamily Hyaeninae |
Family Hyaenidae (organism) |
| Subfamily Lentivirinae (organism) |
Genus Lentivirus (organism) |
| Subfamily Nandiniinae |
Family Nandiniidae (organism) |
| Subfamily Protelinae |
Family Hyaenidae (organism) |
| Subfamily Rynchopinae |
Family Laridae (organism) |
| Subfamily Spumavirinae |
Genus Spumavirus (organism) |
| Subfamily Taxidinae |
Subfamily Mustelinae (organism) |
| Subfamily Ursinae |
Family Ursidae (organism) |
| Subfamily boinae |
Boa |
| fund vedr. subglottis udtrykt ved TNM-systemet |
American Joint Committee on Cancer allowable value |
| røntgenundersøgelse af underkæbespytkirtel |
Plain X-ray of submandibular salivary gland (procedure) |
| Submental flap |
Submental artery flap |
| submukøs injektion af kontraststof mhp. radiografi |
Injection of radiocontrast material |
| Underordenen Cyclorrrhapha - overfamilien Muscoidea |
Suborder Brachycera (organism) |
| Suborder onchopalpida |
Superorder Parasitiformes (organism) |
| Suborder sauria - lizard |
Lizard |
| Suborder tylopoda |
Family Camelidae (organism) |
| Subsequent stage of staged operation NOC |
Subsequent stage of staged operation |
| Subsidiary classification of operations NOS |
Intentional, structural alteration of the human body by mechanical, thermal, light-based, electromagnetic, or chemical means, and/or by the incision or destruction of tissues using instruments to cut, burn, vaporize, freeze, suture, probe, or manipulate by closed reductions. |
| Substance NOS - toxic effect |
Interference in normal bodily functions caused by exposure through ingestion, inhalation, absorption, or injection of a substance (e.g. medicinal product, household product, industrial chemical, or plant or animal derivatives) in quantities that are harmful to health. |
| Substance NOS - toxic effect |
Interference in normal bodily functions caused by exposure through ingestion, inhalation, absorption, or injection of a substance (e.g. medicinal product, household product, industrial chemical, or plant or animal derivatives) in quantities that are harmful to health. |
| Misbrugsstof |
Substance |
| antibiotikagruppen penicillin |
Penicillin |
| stoffremkaldt søvnforstyrrelse |
Drug-induced sleep disorder (disorder) |
| Subtilisin |
Subtilisin |
| subungval glomustumor |
Subungual benign glomus tumor (disorder) |
| Succinyleret gelatine 4 % infusionsvæske, opløsning, flaske a 1 l |
Product containing precisely succinylated gelatin 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Succinyleret gelatine 4 % infusionsvæske, opløsning, flaske a 500 ml |
Product containing precisely succinylated gelatin 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Succinyleret gelatine 4 % infusionsvæske, opløsning, flaske |
Product containing precisely succinylated gelatin 40 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| succinylcholinekstrakt |
Product containing succinylcholine (medicinal product) |
| Sucralfate 1mg tablet |
Product containing precisely sucralfate 1 gram/1 each conventional release oral tablet (clinical drug) |
| sukrose 30 % øjendråber |
Product containing precisely sucrose 300 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Sue Spence-vurdering |
Spence Children's Anxiety Scale |
| sufentanilcitrat 50 µg/ml injektionsvæske, opløsning, ampul |
Sufentanil only product |
| Suffocation by constriction |
Asphyxiation by sustained compression of chest |
| Suicide NOS |
Suicide |
| Suicide NOS |
Suicide |
| Sulfabenzamide + sulfacetamide + sulfathiazole 3.7%ww/2.86%ww/3.42%ww cream |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream |
| sulfabenzamid 3,7 % + sulfacetamid 2,86 % + sulfathiazol 3,42 % vaginalcreme |
Sulfabenzamide 37 mg/mL and sulfacetamide sodium 28.6 mg/mL and sulfathiazole 34.2 mg/mL vaginal cream |
| sulfacetamid 10 % øjensalve |
Sulfacetamide sodium 100 mg/g eye ointment |
| sulfacetamid 10 % lotion |
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) |
| sulfacetamid 2,5 % øjensalve |
Sulfacetamide sodium 25 mg/g eye ointment |
| sulfacetamid 20 % øjendråber |
Sulfacetamide sodium 200 mg/mL eye solution |
| sulfacetamid 30 % øjendråber |
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) |
| sulfacetamid 6 % øjensalve |
Sulfacetamide sodium 60 mg/g eye ointment |
| sulfacetamidnatrium 10 % øjendråber |
Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
| Sulfacetamide sodium 10% ointment |
Sulfacetamide sodium 100 mg/g eye ointment |
| sulfadiazin 1 g/4 ml injektionsvæske |
Sulfadiazine 250 mg/mL solution for injection |
FHIR